- Determinants of acute and chronic renal allograft injury
R.J.M. ten Berge
- Award date
- 17 June 2016
- Number of pages
- Document type
- PhD thesis
- Faculty of Medicine (AMC-UvA)
Renal transplantation researchers have earned big successes by understanding the factors that lead to allorecognition and rejection of solid organ transplants. This knowledge has led to more effective immunosuppressive drug regimens at the cost of an increase in post-transplant infectious diseases and malignancies. Also, with the successes that are acquired with effective immunosuppression, the boundaries of renal transplantation as a therapy have been stretched over the past decades with the introduction of expanded criteria donations, prolonged cold ischemia times, increasing recipient ages and transplantation of immunologically complex cases (e.g. ABO incompatible transplantation). Altogether, this makes both acute, but especially chronic renal allograft failure a true multifactorial disease. This thesis is therefore divided in three parts: factors that define the early post-transplantation period that leads to acute kidney injury of the allograft (Part 1). This early post-transplant period has a large impact on priming of the allo-immune response. In the outpatient setting, the constant interplay between allo-immunity, physiological immune surveillance and immunosupression puts the allograft at risk for rejection, infections and immunosuppressive drug toxicity (Part 2). Ongoing, often subclinical injury to the allograft finally leads to irreversible allograft sclerosis, graft failure and the necessity for new renal replacement therapy (Part 3).
This thesis described differences between various renal allograft injuries and their relative impact on graft failure. We introduced novel findings that might contribute to the way we think about the pathogenesis of ischemia-reperfusion injury, allograft rejection, viral immunity and the final common pathway of chronic allograft injury.
Besides novel finding, also the reproducibility of hypotheses that were proposed by other research groups was tested in large, independent patient cohorts. This cycle of production and reproduction promotes the science that leads to an improvement in the treatment of patients with a renal transplant.
- Research conducted at: Universiteit van Amsterdam
Thesis (complete) (Embargo until 17 June 2018)
Chapter 4: Triggering Receptor Expressed on Myeloid Cells-1 (TREM-1) appears inessential during experimental renal injury and kidney transplantation (Embargo until 17 June 2018)
Chapter 5: Validation of multivariable models for the prediction of delayed graft function after renal transplantation: data from the prospective renal transplantation registry of The Netherlands (NOTR) (Embargo until 17 June 2018)
Chapter 9: Donor and recipient genetic variants in NLRP3 associate with early acute rejection following renal transplantation (Embargo until 17 June 2018)
Chapter 11: Predominant tubular Interleukin-18 expression in polyomavirus-associated nephropathy (Embargo until 17 June 2017)
Chapter 12: Chronic allograft nephropathy (Embargo until 17 June 2018)
Chapter 15: Early conversion to prednisolone and everolimus from a calcineurin inhibitor-containing triple drug therapy as an alternative weaning regimen associated with beneficial renal transplant histology and function: the randomized-controlled MECANO trial (Embargo until 17 June 2018)
If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library, or send a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible.